BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15013048)

  • 1. Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection.
    Arda B; Tunçel M; Yaimazhan T; Gökengin D; Gürel O
    Int J Antimicrob Agents; 2004 Feb; 23(2):204-7. PubMed ID: 15013048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
    J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
    Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
    Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three different combination therapies in the treatment of human brucellosis.
    Ersoy Y; Sonmez E; Tevfik MR; But AD
    Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
    Viale P; Furlanut M; Scudeller L; Pavan F; Negri C; Crapis M; Zamparini E; Zuiani C; Cristini F; Pea F
    Int J Antimicrob Agents; 2009 Apr; 33(4):379-82. PubMed ID: 19097864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of experimental brucellosis of mice and guinea pigs by rifampicin].
    Philippon A; Kazmierczak A; Plommet M; Marly J; Nevot P
    Dev Biol Stand; 1976; 31():279-86. PubMed ID: 816684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
    Karabay O; Sencan I; Kayas D; Sahin I
    BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute post-surgical infection of joint arthroplasty.
    Soriano A; García S; Bori G; Almela M; Gallart X; Macule F; Sierra J; Martínez JA; Suso S; Mensa J
    Clin Microbiol Infect; 2006 Sep; 12(9):930-3. PubMed ID: 16882303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
    Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
    J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of brucellosis using rifampicine (author's transl)].
    Bertrand A; Roux J; Janbon F; Jourdan J; Jonquet O
    Nouv Presse Med; 1979 Nov; 8(44):3635-9. PubMed ID: 534216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis.
    Sezak N; Kuruuzum Z; Cakir N; Yuce A
    J Chemother; 2008 Feb; 20(1):58-62. PubMed ID: 18343745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin in the treatment of experimental brucellosis in mice and guinea pigs.
    Philippon AM; Plommet MG; Kazmierczak A; Marly JL; Nevot PA
    J Infect Dis; 1977 Oct; 136(4):481-8. PubMed ID: 409786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
    Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
    Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
    Barberán J; Aguilar L; Giménez MJ; Carroquino G; Granizo JJ; Prieto J
    Int J Antimicrob Agents; 2008 Aug; 32(2):154-7. PubMed ID: 18571387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
    Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
    Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.
    Blázquez Garrido RM; Espinosa Parra FJ; Alemany Francés L; Ramos Guevara RM; Sánchez-Nieto JM; Segovia Hernández M; Serrano Martínez JA; Huerta FH
    Clin Infect Dis; 2005 Mar; 40(6):800-6. PubMed ID: 15736011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of human brucellosis with rifampicin].
    Godeau P; Fuchs G; Guillevin L; Philippon A; Tucat G; Cabane J; Herson S
    Sem Hop; 1984 Jan; 60(1):5-9. PubMed ID: 6320435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
    Guillaume M; Garraffo R; Bensalem M; Janssen C; Bland S; Gaillat J; Bru JP
    Med Mal Infect; 2012 Sep; 42(9):414-20. PubMed ID: 22944286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
    Bayindir Y; Sonmez E; Aladag A; Buyukberber N
    J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.